SCHEMBL6608776

SCHEMBL6608776

CCc1oc(-c2ccc(F)cc2)nc1CCO

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 7/20 0.42
PPARA Q07869 7/20 0.42
PPARD Q03181 2/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
TARBP2 Q15633 1/20 0.38
UTRN P46939 1/20 0.38
USP2 O75604 1/20 0.37
POLB P06746 1/20 0.37
TSHR P16473 1/20 0.37
TP53 P04637 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
ALDH1A1 P00352 2/20 0.37
ALOX15 P16050 1/20 0.37
MAPT P10636 1/20 0.37
ADCY1 Q08828 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
GCGR P47871 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6607542 0.92 PPARG (0.46) PPARGPPARAPPARDMEN1KMT2A
SCHEMBL6604396 0.88 MEN1 (0.43) PPARGPPARAPPARDMEN1KMT2A
SCHEMBL18095717 0.87 PPARG (0.46) PPARGPPARAPPARDMEN1KMT2A
SCHEMBL18095687 0.87 PPARG (0.54) PPARGPPARAPPARDNPC1RAB9A
SCHEMBL9910339 0.87 ESR2 (0.46) PPARGPPARAPPARDNPC1RAB9A
SCHEMBL6603331 0.85 PPARA (0.47) PPARGPPARAPPARDNPC1RAB9A
SCHEMBL4478993 0.85 PPARG (0.44) PPARGPPARAPPARDUTRNPOLB
SCHEMBL18103290 0.83 TARBP2 (0.56) PPARGPPARAPPARDMEN1KMT2A
SCHEMBL1436051 0.82 PPARA (0.51) PPARGPPARAPPARDNPC1RAB9A
SCHEMBL9910120 0.82 PPARG (0.43) PPARGPPARAPPARDNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1102757-B1 SUBSTITUTED OXAZOLE AND THIAZOLE DERIVATIVES AS HPPAR GAMMA AND HPPAR ALPHA ACTIVATORS GLAXO GROUP LTD (GB) 2004-04-14 EP disclosed
US-6498174-B1 AGONISTS TO PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; MODULATING BLOOD GLUCOSE AND LIPID LEVELS; REDUCING DYSLIPIDEMIA AND HYPERINSULINEMIA ASSOCIATED WITH IMPAIRED GLUCOSE TOLERANCE OR METABOLIC SYNDROME SMITHKLINE BEECHAM CORPORATION 2002-12-24 US disclosed